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Abstract
Purpose Surgical site infections (SSI) are associated with
increased costs and length of hospital stay, readmission rates,
and mortality. The aim of this study was to identify risk factors
for SSI in patients undergoing laparoscopic cholecystectomy.
Methods Analysis of 35,432 laparoscopic cholecystectomies
of a prospective multicenter database was performed. Risk
factors for SSI were identified among demographic data,
preoperative patients’ history, and operative data using multi-
variate analysis.
Results SSIs after laparoscopic cholecystectomy were seen in
0.8 % (n=291) of the patients. Multivariate analysis identified
the following parameters as risk factors for SSI: additional
surgical procedure (odds ratio [OR] 4.0, 95 % confidence
interval [CI] 2.2–7.5), age over 55 years (OR 2.4 [1.8–3.2]),
conversion to open procedure (OR 2.6 [1.9–3.6]), post-
operative hematoma (OR 1.9 [1.2–3.1]), duration of
operation >60 min (OR 2.5 [1.7–3.6], cystic stump insuffi-
ciency (OR 12.5 [4.2–37.2]), gallbladder perforation (OR 6.2
[2.4–16.1]), gallbladder empyema (OR 1.7 [1.1–2.7]), and
surgical revision (OR 15.7 [10.4–23.7]. SSIs were associated
with a significantly prolonged hospital stay (p<0.001), higher
postoperative mortality (p<0.001), and increased rate of
surgical revision (p<0.001).
Conclusions Additional surgical procedure was identified as a
strong risk factor for SSI after laparoscopic cholecystectomy.
Furthermore, operation time >60 min, age >55 years, conver-
sion to open procedure, cystic stump insufficiency, postoper-
ative hematoma, gallbladder perforation, gallbladder empy-
ema, or surgical revision were identified as specific risk fac-
tors for SSI after laparoscopic cholecystectomy.
Keywords Laparoscopic cholecystectomy . Surgical site
infection . Risk factor . Morbidity . Mortality
Introduction
Surgical site infections (SSI) are associated with increased
costs and readmission rates [1, 2]. The incidence of postoper-
ative SSI has decreased with the introduction of laparoscopic
procedures in comparison to open procedures [3–5]. Several
risk factors to develop SSI after laparoscopic gastrointestinal
surgery were identified in previous studies including
long operation time, obesity, age, emergency procedure,
American Society of Anesthesiologists (ASA) score, and male
gender [4, 6, 7]. The use of prophylactic antibiotics reduced
the incidence of postoperative SSI after laparoscopic chole-
cystectomy only in part; however, additional factors impact on
the incidence of SSI [8, 9]. Laparoscopic cholecystectomy is
frequently performed as an additional procedure during lapa-
roscopic upper GI, bariatric, and colorectal surgeries, and we
hypothesized that additional procedures impact on the
incidence of postoperative SSI [10].
The aims of this multicenter registry-based study were to
evaluate the incidence of postoperative SSI after laparoscopic
cholecystectomy and to elucidate risk factors and in particular
the role of additional surgical procedures for the development
of SSI during a short-term postoperative follow-up.
Materials and methods
The prospective database of the Swiss Association of
Laparoscopic and Thoracoscopic Surgery (SALTC), with vol-
untary participation of over 70 Swiss surgical divisions,
consisting of all consecutive patients undergoing laparoscopic
cholecystectomies in Switzerland between 1995 and 2008was
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explored. All data were collected prospectively and entered in
a centralized database (Qualicare®, Qualidoc, Liebefeld,
Bern, Switzerland) by an independent data manager and were
analyzed in a retrospective manner.
Demographic and clinical outcome parameters regarding
age, gender, body mass index (BMI), previous biliary pancre-
atitis or endoscopic retrograde cholangiopancreatography,
elective or emergency procedure, primary or additional surgi-
cal procedure, indication for laparoscopic cholecystectomy,
use of intraoperative cholangiography, duration of operation,
conversion to open procedure, surgeon’s experience measured
by quantity of laparoscopic cholecystectomies, ASA score,
need of surgical revision, postoperative hematoma (abdominal
wall or abdominal cavity), perforation of gallbladder, cystic
stump insufficiency, postoperative need of ICU therapy,
length of hospital stay, in-hospital mortality, and occurrence
of SSI were analyzed. Incidence of SSI was assessed in an
adapted manner to previously published criteria [11] and
included superficial incisional SSI, deep incisional SSI, and
organ/space SSI. The study population was then divided into a
group with and without documented SSI, and each recorded
parameter was then analyzed for possible risk factor for SSI
after laparoscopic cholecystectomy.
Statistics
Continuous variables are expressed as median with range and
compared using unpaired t test. Preoperative characteristics and
surgery-related data were compared using Pearson’s chi-square
or Fisher’s exact test as appropriate for categorical variables.
Multivariate binary logistic regression analysis was used
for the analysis of risk factors for SSI. Parameters with p<0.2
were included into multivariate logistic regression analysis.
Data with p<0.05 were considered as statistically significant,
and adjusted odds ratio with 95 % confidence intervals was
derived from logistic regression analysis. Statistical analysis
of the data was performed with SPSS 20.0 software package
(SPSS, Chicago, IL, USA).
Results
Between 1995 and 2008, 35,432 patients undergoing laparo-
scopic cholecystectomy were included into the database. The
incidence of SSI after laparoscopic cholecystectomy was
0.8 % (291/35,432). In the majority of patients superficial
incisional SSI (type I) occurred, and organ/space SSI (type
III) occurred only in a minority of patients (Table 1). Patients’
demographic characteristics and surgical details are given in
Table 2 according to the presence of the outcome variable SSI.
Laparoscopic cholecystectomy was performed as primary
surgical procedure in 98.8 % and an additional procedure in
1.2 % of the patients. The postoperative mortality was signif-
icantly increased after SSI than without SSI (2.1 vs 0.2 %,
p<0.001). Length of hospital stay was significantly prolonged
in patients with SSI than those without SSI (11 vs 3 days,
p<0.001, Table 2).
Use of intraoperative cholangiography, BMI, symptomatic
cholelithiasis, incidence of gallbladder cancer, previous biliary
pancreatitis, surgeon’s experience, and antibiotic prophylaxis
had no significant impact in univariate analysis on the inci-
dence of SSI.
Postoperative course and complications are given in
Table 3. The incidence of postoperative complications was
Table 1 Total incidence
of SSI and distribution of
subtypes
Values are numbers (%)
SSI surgical site infection
SSI Total 291 (100)
Type 1 273 (93.8)
Type 2 17 (5.9)
Type 3 1 (0.3)
Table 2 Demographic and technical operation data
SSI group Non-SSI group p valueb,c
n=291 n=35,141
Age (years)a,c 67.1 (18–92) 55.4 (3–100) <0.001
Gender
Male 123 (42.3) 11,446 (32.6) <0.001
BMI (kg/m2)a,c 27.98 27.56 0.266
ASA scorea,c 2 (1–5) 2 (1–4) <0.001
Exitus 6 (2.1) 61 (0.2) <0.001
Hospital stay (days)a,c 11 (1–87) 3 (0–374) <0.001
Additional surgical procedure 14 (4.8) 403 (1.1) <0.001
Cholecystolithiasis 281 (96.6) 34,294 (97.6) 0.247
Acute cholecystitis 105 (36.1) 7,698 (21.9) <0.001
Gallbladder empyema 25 (8.6) 935 (2.7) <0.001
Previous ERCP 55 (18.9) 4,775 (13.6) 0.011
Previous biliary pancreatitis 30 (10.3) 2,576 (7.3) 0.051
Intraoperative
cholangiography
104 (35.7) 12,538 (35.7) 1.000
Emergency procedure 70 (24.1) 5,637 (16.0) <0.001
Conversion to open procedure 69 (23.7) 2,078 (5,0) <0.001
Gallbladder perforation 11 (3.8) 22 (0.1) <0.001
Surgeon’s experience
>50 operations 215 (73.9) 26,899 (76.5) 0.298
Duration of operation (min)
>60 min 181 (62.2) 11,746 (33.4) <0.001
aValues are median (range)
b Fisher’s exact test unless indicated otherwise
c Unpaired t test
SSI surgical site infection, ASA American Society of Anesthesiol-
ogists, BMI body mass index, ERCP endoscopic retrograde
cholangiopancreatography
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significantly increased in the SSI group compared to the group
without SSI (46.7 vs 2.4 %, p<0.001). Patients with SSI had
significantly higher incidence for hematoma in the abdominal
wall (5.8 vs 0.6 %, p<0.001) and abdominal cavity (5.5 vs
0.6 %, p<0.001).
An additional surgical procedure together with laparoscop-
ic cholecystectomy was associated with an increased risk for
SSI (p<0.001). Further, additional surgical procedures to the
initial cholecystectomy were associated with a significantly
increased risk for cystic stump insufficiency (p=0.035,
Table 4).
The multivariate logistic regression analysis of the inde-
pendent risk factors revealed additional surgical procedure as
a significant risk factor for SSI among others (Table 5). The
association of operation time and incidence of SSI are
shown in Fig. 1 with a distinct increase of the frequency of
infections in operations with a prolonged duration of more
than 60 min.
Discussion
The incidence of SSI after laparoscopic cholecystectomy is
infrequent. This study identified several risk factors for SSI. In
particular, additional surgical procedure is a risk factor that
can be addressed in the clinical routine.
Importantly, laparoscopic cholecystectomy as an additional
surgical procedure during, e.g., fundoplication, bariatric sur-
gery, or gastric surgery, was a risk factor for SSI. A potential
reason for that finding is a prolonged duration of operation as
two operations are performed during one surgical procedure,
which is associated with an increase of SSI. In addition of that,
cholecystectomy as additional surgical procedure was associ-
ated with a significantly higher rate for cystic stump insuffi-
ciency and a higher incidence for intra-abdominal bleeding.
Both factors for themselves were identified as risk factors for
SSI in this analysis. On the other hand, the incidence of SSI is
probably not only determined by the cholecystectomy itself
but to the second operation. However, it was impossible to
elucidate this problem in detail on the basis of the present
database, as well as the impact whether laparoscopic chole-
cystectomy was the primary or the secondary operation.
Nevertheless, the indication to perform a cholecystectomy
during a second operation should be carefully selected.
Table 3 Univariate analysis of postoperative complications
SSI group Non-SSI group p valuea
n=291 n=35,141
Surgical revision 70 (24.1) 260 (0.7) <0.001
Postoperative ICU 26 (8.9) 154 (0.4) <0.001
Postoperative hematoma 33 (11.3) 418 (1.2) <0.001
Cystic stump insufficiency 7 (2.4) 18 (0.1) <0.001
Values are numbers (%)
a Fisher’s exact test
SSI surgical site infection, ICU intensive care unit
Table 4 Univariate analysis of postoperative complications after laparo-
scopic cholecystectomy as primary or additional surgical procedure
Primary
procedure
Additional
procedure
p valuea
n=35,015 n=417
SSI 277 (0.8) 14 (3.4) <0.001
Hematoma abdominal wall 235 (0.7) 2 (0.5) 1.000
Hematoma abdominal 1cavity 221 (0.6) 6 (1.4) 0.053
Cystic stump insufficiency 23 (0.1) 2 (0.5) 0.035
Values are numbers (%)
a Fisher’s exact test
SSI surgical site infection
Table 5 Multivariate binary logistic regression analysis of independent
risk factors for SSI
Odds ratio (95 % CI) p value
Additional surgical procedure 4.011 (2.149–7.486) <0.001
Age >55 years 2.398(1.777–3.235) <0.001
Conversion to open procedure 2.647 (1.935–3.621) <0.001
Postoperative hematoma 1.910 (1.192–3.060) 0.007
Duration of operation >60 min 2.493 (1.710–3.635) <0.001
Cystic stump insufficiency 12.451 (4.169–37.189) <0.001
Gallbladder perforation 6.161 (2.365–16.047) <0.001
Gallbladder empyema 1.704 (1.080–2.689) 0.022
Surgical revision 15.725 (10.439–23.686) <0.001
SSI surgical site infection
Fig. 1 Incidence of SSI after laparoscopic cholecystectomy in relation-
ship to duration of operation
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The incidence of 0.8 % of SSI after laparoscopic cholecys-
tectomy in this study was low but is comparable to that of the
previous reports with an incidence between 0.6 and 1.1 % [7,
8, 12, 13]. With the introduction of laparoscopic cholecystec-
tomy, the incidence of postoperative infections decreased
compared to that of the open cholecystectomy [4, 7, 14].
The routine use of preoperative prophylactic antibiotics has
been shown not to reduce the incidence of postoperative
infections mainly after elective laparoscopic cholecystectomy.
There are some small prospective studies, in which there was
no reduction of SSI despite of antibiotics, whereas the overall
incidence of SSI was lowwhich both correspond to our results
[8, 9, 15].
Patients older than 55 years were more predisposed for SSI
than younger patients in this investigation. One reason might
be that patients with SSI had significantly higher ASA score
reflecting the collective of older patients in this study. Higher
ASA score was reported as risk factor for SSI after laparo-
scopic cholecystectomy and colorectal surgery [6, 7].
Increased duration of operation longer than 60 min was
associated with an increase of SSI in this investigation.
Several studies have shown that an increase of the duration
of the surgical procedure is associated with an increase of SSI
[6, 16–18]. Advanced disease or inflammation of the gallblad-
der might be one reason for prolonged duration of the opera-
tion and therefore associated with an increase of SSI.
The increased rate of SSI after loss of bile fluid into the
abdominal cavity might be explained as bacteribilia in patients
undergoing laparoscopic cholecystectomy that is common
and was already shown as risk factor for SSI in open chole-
cystectomy, whereas others could not detect a relationship
between infected bile and the incidence of SSI [8, 9, 19–21].
The fact that acute cholecystitis or gallbladder empyema was
found as risk factors for SSI after laparoscopic cholecystecto-
my in this study, the infectious state of the bile seems to be a
relevant cofactor for the development of SSI.
Open cholecystectomy has been shown to be associated
with an increased rate of SSI than laparoscopic cholecystec-
tomy [5, 13, 22]. Therefore, it is not surprising that conversion
to an open procedure during laparoscopic cholecystectomy
was associated with an increase of SSI in this investigation.
On the other hand, conversion to laparotomy is mostly neces-
sary due to technical problems or unclear anatomical situation
with probable increase of intraoperative complications and
consecutively higher risk for SSI.
The present study is limited by the biases that are typically
associated with the analysis of outcome registries: Precision
and completeness of data acquisition are very difficult to
control and to evaluate specific questions that are sometimes
impossible to address (e.g., exact localization of infection and
use of harvesting bag). The quality and validity of such
a large multicenter database are dependent on the collabo-
ration of each participating surgical center. There is often not a
centralized control institution to check the correctness and
completeness of the data. This study is based on short-term
in-hospital outcome and does not reflect a 30-day follow-up as
required in accordance with the Centers for Disease Control
and Prevention guidelines, so that a certain percentage of
patients with SSI dropped out of the database [11]. Thus, the
incidence of SSI might be underestimated in this database as,
e.g., wound infections often occur later than the median hos-
pital stay of 3 days in the non-SSI group. In order to omit
such bias, prospective protocols are required with a longer
follow-up.
Conclusion
In conclusion, this analysis of a nationwide multicenter data-
base revealed independent risk factors for SSI after laparo-
scopic cholecystectomy such as age, acute cholecystitis, gall-
bladder empyema, conversion, duration of operation, and
surgical complications. In particular, cholecystectomy as ad-
ditional surgical procedure seems to be an important addition-
al risk factor that can be addressed during the planning of an
operation. On the basis of these results, the surgeon’s tech-
nique, timing, and indication for the operation may influence
the risk of SSI besides of patient-related factors.
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